765 results
8-K
EX-99.1
ABT
Abbott Laboratories
17 Apr 24
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
7:36am
on the following page.
-- more --
Page 9 of 15
1)2024 Taxes on Earnings includes the recognition of approximately $10 million of net tax expense … as a result of the resolution of various tax positions related to prior years.
2023 Taxes on Earnings includes the recognition of approximately $22
8-K
ABT
Abbott Laboratories
17 Apr 24
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
7:36am
, certain regulatory costs, tax benefits associated with specified items, net tax expense as a result of the resolution of various tax positions related … to prior years, and excess tax benefits associated with share-based compensation. These non-GAAP financial measures also exclude intangible amortization
8-K
vtzy5
24 Jan 24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
7:36am
8-K
EX-99.1
llw 8rw18
24 Jan 24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
7:36am
8-K
r8bgfjhfr6ijrsv68
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
8-K
EX-99.1
kofn45 uqfolzx66w
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
8-K
pnxk jagm9b
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
8-K
EX-99.1
hpas8sv
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
11-K
zu90x8rku9
23 Jun 23
Annual report of employee stock purchases
4:07pm